Taken together with the studies focused on CD1d expression by tumors, this suggests a role for agents that induce CD1d-mediated antigen presentation as means of enhancing NKT cell-mediated cancer immune surveillance in the tumor microenvironment (Figure 1). This evidence concerns the gene CD1D and cancer.